- Diversity and Antiaflatoxigenic Activities of Culturable Filamentous Fungi from Deep-Sea Sediments of the South Atlantic Ocean
-
Zhou Y, Gao X, Shi C, Li M, Jia W, Shao Z, Yan P
- KMID: 2519084
- Mycobiology.
- 2021 Apr;49(2):151-160.
- doi: 10.1080/12298093.2020.1871175
Despite recent studies, relatively few are known about the diversity of fungal communities in the deep Atlantic Ocean. In this study, we investigated the diversity of fungal communities in 15... -
- CITED
-
- Close
- SHARE
-
- Close
- Interaction between Brucella melitensis 16M and small ubiquitin-related modifier 1 and E2 conjugating enzyme 9 in mouse RAW264.7 macrophages
-
Yi J, Wang Y, Li Q, Zhang H, Shao Z, Deng X, He J, Xiao C, Wang Z, Wang Y, Chen C
- KMID: 2464100
- J Vet Sci.
- 2019 Sep;20(5):e54.
- doi: 10.4142/jvs.2019.20.e54
Brucella is an intracellular pathogen that invades a host and settles in its immune cells; however, the mechanism of its intracellular survival is unclear. Modification of small ubiquitin-related modifier (SUMO)... -
- CITED
-
- Close
- SHARE
-
- Close
- Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway
-
Xu Z, Hu J, Cao H, Pilo MG, Cigliano A, Shao Z, Xu M, Ribback S, Dombrowski F, Calvisi DF, Chen X
- KMID: 2438347
- Exp Mol Med.
- 2018 Jan;50(1):e417.
- doi: 10.1038/emm.2017.158
Hepatocellular carcinoma (HCC) is a deadly malignancy with limited treatment options. Activation of the AKT/mTOR cascade is one of the most frequent events along hepatocarcinogenesis. mTOR is a serine/threonine kinase... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of DNA Damage Response Proteins and Associations with Clinicopathologic Characteristics in Chinese Familial Breast Cancer Patients with BRCA1/2 Mutations
-
Zhu X, Tian T, Ruan M, Rao J, Yang W, Cai X, Sun M, Qin G, Zhao Z, Wu J, Shao Z, Shui R, Hu Z
- KMID: 2421370
- J Breast Cancer.
- 2018 Sep;21(3):297-305.
- doi: 10.4048/jbc.2018.21.e38
PURPOSE: The characteristic expression of DNA damage response proteins in familial breast cancers with BRCA1, BRCA2, or non-BRCA1/2 mutations has not been analyzed in Chinese patients. Our study aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
